35.80
+2.20
+(6.55%)
As of 8:03:30 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 285.91M | 301.71M | 1.23B | 1.32B |
| Low Estimate | 283.4M | 295.6M | 1.22B | 1.3B |
| High Estimate | 290.88M | 310.91M | 1.26B | 1.35B |
| Year Ago Sales | 265.78M | 279.65M | 1.14B | 1.23B |
| Sales Growth (year/est) | 7.57% | 7.89% | 7.68% | 7.41% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BB1.F | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Barrington Research: Outperform to Outperform | 3/12/2025 |
| Maintains | Barrington Research: Outperform to Outperform | 12/11/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 11/7/2024 |
| Maintains | Roth MKM: Buy to Buy | 11/7/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 10/29/2024 |
| Maintains | Roth MKM: Buy to Buy | 8/1/2024 |